1、White paper/AI Transformation of Business Development in the Generics Industry1AI Transformation of Business Development in the Generics IndustryContents01/Executive Summary 202/Introduction 503/Challenges in Generics Business Development(Pre-AI)904/AI as a Game-Changer for Generics BD 1305/A case e

2、xample 2306/Technical Foundations:How AI Models Drive BD Insights 2707/Real-World Impact and Looking Ahead 3208/Conclusion 362AI Transformation of Business Development in the Generics IndustryExecutive Summary01/3AI Transformation of Business Development in the Generics IndustryExecutive Summary01/B

3、usiness development(BD)teams in the generics pharmaceutical industry face high-stakes decisions as blockbuster drugs lose exclusivity(LOE)and new opportunities emerge.AI is revolutionising this process by providing data-driven insights that were previously unattainable with manual methods.This white

4、 paper explores how AI helps BD teams:Evaluatecandidatemoleculesforgenericdevelopmentbyscanningvastdatasources(patents,clinicaltrials,salesdata)toidentifyhigh-potentialopportunitiespost-LOE.Understandtotaladdressablemarketsizeforeachmoleculebyaggregatingandanalysingglobaldemandsignals,tenderadoption

5、ratesandtendernetprices,prescriptionvolumes,andsalesfigures.AnalysenetpriceevolutionafterLOEusingpredictivemodelsthatlearnfromhistoricalLOEcaseswithmoregranularML/Deeplearning-basedanalogselectionmethodstoforecastpriceerosionandcompetitivedynamics.BuildrobustbusinesscaseswithAI-drivenforecastingofre

6、venuesandmarketshare,enablingconfidentinvestmentdecisionsandstrategyformulation.4AI Transformation of Business Development in the Generics IndustryWe highlight Vamstars AI capabilities as a case example of this transformation focusing on technical insights and real-world applications.Real case studi